International Stem Cell's other current assets is $190K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
International Stem Cell posts a other current assets of $190K as of June 2026. That compares with $220K in the prior-year period — down 13.8% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.
In the prior comparable period, International Stem Cell's other current assets was $220K. The latest reading is $190K — a 13.8% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.
Other Current Assets is one piece of International Stem Cell's financial statement story. At $190K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.
Context for ISCO's other current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; International Stem Cell's other metric pages and overview cover the third.
Judging International Stem Cell against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in other current assets easier to interpret. Start with $190K here, then scan peer and history charts to see if the gap is persistent.